Published in Nat Clin Pract Gastroenterol Hepatol on February 01, 2007
Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol (2012) 1.26
Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol (2009) 1.01
Genetic determination of irritable bowel syndrome. World J Gastroenterol (2008) 0.97
T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome. Inflammation (2010) 0.93
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome. PLoS One (2013) 0.88
Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndrome. J Gastroenterol (2013) 0.79
Pimpinella anisum in modifying the quality of life in patients with functional dyspepsia: A double-blind randomized clinical trial. J Res Med Sci (2014) 0.78
Molecular basis of the irritable bowel syndrome. World J Gastroenterol (2014) 0.78
Gene polymorphisms associated with functional dyspepsia. World J Gastroenterol (2015) 0.77
Pimpinella anisum in the treatment of functional dyspepsia: A double-blind, randomized clinical trial. J Res Med Sci (2015) 0.77
Neuropeptide s receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders (gastroenterology 2010;138:98-107). J Neurogastroenterol Motil (2010) 0.75
Optimal management of constipation associated with irritable bowel syndrome. Ther Clin Risk Manag (2015) 0.75
Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial. BMC Gastroenterol (2013) 0.75
Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome. World J Gastroenterol (2016) 0.75
Lack of Association between Interleukin 12 C(-1188)A Polymorphism and Irritable Bowel Syndrome. Avicenna J Med Biotechnol (2011) 0.75
Functional gastroduodenal disorders. Gastroenterology (2006) 8.51
A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med (2006) 2.94
Immune activation in patients with irritable bowel syndrome. Gastroenterology (2007) 2.82
Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes. Gut (2012) 2.36
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli. Gastroenterology (2009) 1.78
MR colonography with barium-based fecal tagging: initial clinical experience. Radiology (2002) 1.67
Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterology (2008) 1.63
G protein-coupled receptor kinase 6 controls post-inflammatory visceral hyperalgesia. Brain Behav Immun (2008) 1.49
Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. AJR Am J Roentgenol (2003) 1.46
Recurrent symptoms after fundoplication with a negative pH study--recurrent reflux or functional heartburn? J Gastrointest Surg (2008) 1.44
On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study. J Clin Gastroenterol (2007) 1.39
Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol (2008) 1.17
Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol (2004) 1.13
MR colonography in patients with incomplete conventional colonoscopy. Radiology (2004) 1.09
Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model. Pain (2006) 1.09
Increased visceral sensitivity to capsaicin after DSS-induced colitis in mice: spinal cord c-Fos expression and behavior. Am J Physiol Gastrointest Liver Physiol (2007) 1.07
Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome? Am J Gastroenterol (2004) 0.99
Do we know what patients want? The doctor-patient communication gap in functional gastrointestinal disorders. Clin Gastroenterol Hepatol (2009) 0.98
Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. Am J Gastroenterol (2011) 0.95
Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome. Am J Gastroenterol (2006) 0.94
Hypothesis driven research and molecular mechanisms in functional dyspepsia: the beginning of a beautiful friendship in research and practice? Am J Gastroenterol (2006) 0.88
Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients. J Gastroenterol Hepatol (2007) 0.88
Ablation of connexin43 in smooth muscle cells of the mouse intestine: functional insights into physiology and morphology. Cell Tissue Res (2006) 0.84
Molecular basis of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol (2004) 0.84
Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study. Clin Drug Investig (2011) 0.84
Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol (2007) 0.84
Papillomatosis confined to the distal biliary tract--a rare cause of obstructive jaundice: report of a case. Surg Today (2003) 0.83
Real-time high-resolution MRI for the assessment of gastric motility: pre- and postpharmacological stimuli. J Magn Reson Imaging (2004) 0.83
Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. J Gastroenterol (2015) 0.83
Effect of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension. Eur J Gastroenterol Hepatol (2002) 0.83
Psychological stress and the severity of post-inflammatory visceral hyperalgesia. Eur J Pain (2006) 0.83
GERD evaluation: time for a new paradigm? J Clin Gastroenterol (2007) 0.81
An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementation. Inflamm Bowel Dis (2011) 0.81
Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines. Digestion (2009) 0.81
Non-erosive reflux disease--defining the entity and delineating the management. Digestion (2008) 0.80
Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders--an evaluation study. BMC Health Serv Res (2009) 0.80
Functional dyspepsia. Curr Opin Gastroenterol (2016) 0.80
GERD 2003 -- a consensus on the way ahead. Digestion (2003) 0.79
Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndrome. J Gastroenterol (2013) 0.79
A combination of peppermint oil and caraway oil attenuates the post-inflammatory visceral hyperalgesia in a rat model. Scand J Gastroenterol (2006) 0.77
Cost and time savings from a rapid access model of care using transient elastography to screen and triage patients with chronic Hepatitis C infection. J Med Econ (2013) 0.77
Serotoninergic and non-serotoninergic effects of two tricyclic antidepressants on visceral nociception in a rat model. Scand J Gastroenterol (2009) 0.76
Serum ferritin and survival of renal transplant recipients: a prospective 10-year cohort study. Transpl Int (2003) 0.76
IBD: Stress causes flares of IBD--how much evidence is enough? Nat Rev Gastroenterol Hepatol (2011) 0.76
Are all symptoms in patients in IBD due to occult inflammation? Am J Gastroenterol (2010) 0.75
(Post) inflammatory visceral hyperalgesia: don't we believe what we don't see? Gastroenterology (2002) 0.75
Recombinant human erythropoietin counteracts cisplatin-induced visceral hyperalgesia. Neurosci Bull (2010) 0.75
Colonic transit studies with 99mTc-rhenium sulfide colloid in live rats. A preliminary study. Hell J Nucl Med (2008) 0.75
Does doctors' knowledge of inflammatory bowel disease patients' psychological status affect patients' clinical outcomes: a pilot randomized controlled trial. Eur J Gastroenterol Hepatol (2009) 0.75
Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. Crit Care Med (2017) 0.75
Intraoperative cholangioscopy in the management of biliary adenomas. J Surg Oncol (2004) 0.75
[New drugs for the treatment of constipation]. Med Klin (Munich) (2010) 0.75
[Intensive Care Management of Severe Infections in Cancer Patients]. Dtsch Med Wochenschr (2019) 0.75